Publications by authors named "George Olt"

Claim this Profile
S
Secondary surgical cytoreduction for advanced ovarian carcinoma.
Peter G Rose, Stacy Nerenstone, Mark F Brady, Daniel Clarke-Pearson, George Olt

N Engl J Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
David H Moore, John A Blessing, Richard P McQuellon, Howard T Thaler, David Cella, George Olt

J Clin Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.
J Tate Thigpen, John A Blessing, George Olt, Samuel S Lentz, Jeffrey Bell

Gynecol Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue and gynecologic cancer.
George J Olt

Curr Womens Health Rep· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Steven C Plaxe, John A Blessing, George Olt, Nader Husseinzadah, Samuel S Lentz

Cancer Chemother Pharmacol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a retinol dehydrogenase (hRoDH-4), a member of the retinol/steroid dehydrogenase family implicated in retinoic acid biosynthesis, in normal and neoplastic endometria.
Joanna M Cain, Richard Zaino, Debra Shearer, R Alan Bennett, George Olt

Am J Obstet Gynecol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis